CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-02 | Knowles Julius Director | Sale | −5,705 | $53.86 | $307K | 251,626 |
| 2021-12-02 | Knowles Julius Director | Sale | −138 | $54.67 | $8K | 370,416 |
| 2021-12-02 | Knowles Julius Director | Sale | −90 | $54.67 | $5K | 251,536 |
| 2021-12-01 | Knowles Julius Director | Sale | −4,243 | $53.48 | $227K | 395,014 |
| 2021-12-01 | Knowles Julius Director | Sale | −2,766 | $53.48 | $148K | 267,580 |
| 2021-12-01 | Knowles Julius Director | Sale | −5,168 | $54.67 | $283K | 389,846 |
| 2021-12-01 | Knowles Julius Director | Sale | −3,372 | $54.67 | $184K | 264,208 |
| 2021-12-01 | Knowles Julius Director | Sale | −2,528 | $55.71 | $141K | 387,318 |
| 2021-12-01 | Knowles Julius Director | Sale | −1,649 | $55.71 | $92K | 262,559 |
| 2021-12-01 | Knowles Julius Director | Sale | −1,566 | $56.27 | $88K | 385,752 |
| 2021-12-01 | Knowles Julius Director | Sale | −1,021 | $56.27 | $57K | 261,538 |
| 2021-11-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 91,000 |
| 2021-11-11 | Lachey Jennifer Chief Scientific Officer | Sale | −739 | $58.73 | $43K | 90,261 |
| 2021-11-11 | Lachey Jennifer Chief Scientific Officer | Sale | −4,561 | $59.78 | $273K | 85,700 |
| 2021-11-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −5,300 | 97,905 | ||
| 2021-11-10 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +15,900 | $0.30 | $5K | 101,600 |
| 2021-11-10 | Lachey Jennifer Chief Scientific Officer | Sale | −15,900 | $60.00 | $954K | 85,700 |
| 2021-11-10 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −15,900 | 103,205 | ||
| 2021-11-04 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +10,600 | $0.30 | $3K | 96,300 |
| 2021-11-04 | Lachey Jennifer Chief Scientific Officer | Sale | −10,600 | $50.00 | $530K | 85,700 |
Page 14 of 36 · 707 trades